De Facto hired by Swedish drugs firm

Healthcare shop De Facto has been brought on board by pharmaceutical service provider Recipharm to build its reputation among key stakeholders.

De Facto co-founder and director Kevin Payne
De Facto co-founder and director Kevin Payne

The agency is charged with positioning the Swedish firm as a leader in the drug development and manufacturing services sector

Recipharm is looking to grow by 20 per cent per year and aims to challenge the dominance of the world's top three contract manufacturing organisations.

De Facto will handle an extensive international media outreach programme and secure pieces in influential sector publications.

It will also highlight Recipharm's in-house development and formulation expertise through a series of articles and case studies in the technical press.

De Facto co-founder and director Kevin Payne will lead the account.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in